Two chlorzoxazone (Parafon forte) overdoses and coma in one patient: Reversal with flumazenil

American Journal of Emergency Medicine

Volumn 16, Issue 4, 1998, Pages 393-395

  Roberge, Raymond J ^a,c   Atchley, Brett ^b   Ryan, Kenneth ^b   Krenzelok, Edward P ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c WESTERN PENNSYLVANIA HOSPITAL   (United States)

Author keywords

Chlorzoxazone; Coma; Flumazenil; Overdose; Reversal

Indexed keywords

BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; CHLORZOXAZONE; DISULFIRAM; FLUMAZENIL; OXAZEPAM; PHENOBARBITAL;

ADULT; ALCOHOLISM; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CLINICAL FEATURE; COMA; DRUG ANTAGONISM; DRUG EFFICACY; DRUG INTOXICATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0031855539     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-6757(98)90137-1     Document Type: Article

References (15)

1. AMA Drug Evaluation (ed 7). Chicago, IL, American Medical Association, Department of Drugs, 1992, p 394
2. Powers BJ, Cattau Jr EL, Zimmerman HJ: Chlorzoxazone hepatotoxic reactions: An analysis of 21 identified or presumed cases. Arch Intern Med 1986;146:1183-1186
3. Physicians Desk Reference (ed 49). Montvale, NJ, Medical Economics Data Production Company, 1995, p 1471
4. Matthews RT, McMillen BA, Speciale SG, et al: Effects of zoxazolamine and related centrally acting muscle relaxants on nigrostriatial dopaminergic neurons. Brain Res Bull 1984;12:479-486
5. Kim RB, O'Shea D, Wilkinson GR: Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms. Clin Pharmacol Ther 1995; 57:645-655
6. Girre C, Lucas D, Hispard E, et al: Assessment of cytochrome P450 2E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics. Biochem Pharmacol 1994;47:1503-1508
7. Yasuhara M, Levy G: Pharmacodynamics of zoxazolamine and chlorzoxazone in rats. Pharmaceut Res 1988;5:401-407
8. Desiraju RK, Renzi Jr NL, Nayak RK, et al: Pharmacokinetics of chlorzoxazone in humans. J Pharmaceut Sci 1983;72:991-994
9. Reynolds JEF (ed): Martindale: The Extra Pharmcopoeia (ed 28). London, The Pharmaceutical Press, 1982, p 988
10. Karasch ED, Thummel KE, Mhyre J, et al: Single-dose disulfiram inhibition of chlorzoxazone metabolism: A clinical probe for P450 2E1. Clin Pharacol Ther 1993;53:643-650
11. Liederman PC, Boldus RA: Psychic side effects of a chlorzoxazone and acetaminophen mixture. JAMA 1967;202:64-66
12. Rosin MA: Chlorzoxazone-induced spasmodic torticollis. JAMA 1981:246:2575 (letter)
13. Nightingale SL: Chlorzoxazone warning on hepatotoxicity is strengthened. JAMA 1995:274:1903 (letter)
14. O'Sullivan GF, Wade DN: Flumazenil in the management of acute drug overdose with benzodiazepines and other agents. Clin Pharmacol Ther 1987;41:254-259
15. Saissy JM, Vitris M, Demaziere J, et al: Flumazenil counteracts intrathercal baclofen-induced central nervous system depression in tetanus. Anesthesiology 1992;76:1051-1053